EXC.NASDAQExelon CORP

Form 4: Exelon Director Bryan K Segedi Reports Acquisition of Deferred Stock Units

Sentiment:

SEC Form 4 Filing


Director Bryan K Segedi reports acquiring 1,161 deferred stock units of Exelon Corp on June 30, 2024, at a price of $35.54.

Summary

  • On June 30, 2024, Bryan K Segedi, a director of Exelon Corp, acquired 1,161 shares of common stock in the form of deferred stock units.
  • The price per share was $35.54.
  • This transaction increased Segedi's indirect beneficial ownership to 2,304 shares, including 12 shares acquired through automatic dividend reinvestment, held through the Exelon Directors Deferred Stock Unit Plan.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, neither particularly positive nor negative.

Industry Context

Form 4 filings are standard practice for corporate insiders to report transactions in their company's stock, providing transparency to the market.

Comparison to Industry Standards

  • Directors commonly receive stock or deferred stock units as part of their compensation.
  • The specifics of these arrangements vary widely across companies and industries.
  • Comparing Segedi's holdings and transactions to those of directors at peer utilities like Duke Energy (DUK) or Southern Company (SO) would provide additional context.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding insider activity.
  • It has a minimal direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
06/30/2024Date of transaction: Acquisition of deferred stock units
07/02/2024Date of signature by attorney-in-fact

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.